NAP
GILD icon

New Amsterdam Partners’s Gilead Sciences GILD Stock Holding History

New Amsterdam Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,789
Closed -$532K – 132
2016
Q1 		$532K Sell
5,789
-518
-8% -$46.7K 0.06% 103
2015
Q4 		$638K Sell
6,307
-1,780
-22% -$185K 0.07% 106
2015
Q3 		$794K Buy
8,087
+20
+0.2% +$2.22K 0.08% 100
2015
Q2 		$944K Sell
8,067
-23,332
-74% -$2.55M 0.08% 92
2015
Q1 		$3.08M Sell
31,399
-15,060
-32% -$1.53M 0.25% 96
2014
Q4 		$4.38M Sell
46,459
-2,951
-6% -$305K 0.38% 57
2014
Q3 		$5.26M Sell
49,410
-2,255
-4% -$221K 0.35% 56
2014
Q2 		$4.28M Buy
51,665
+3,466
+7% +$270K 0.28% 59
2014
Q1 		$3.42M Buy
48,199
+1,213
+3% +$95.1K 0.23% 71
2013
Q4 		$3.53M Sell
46,986
-562
-1% -$39.1K 0.23% 71
2013
Q3 		$2.99M Sell
47,548
-97,275
-67% -$5.81M 0.2% 80
2013
Q2 		$7.42M Buy
+144,823
New +$7.55M 0.4% 93

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New Amsterdam Partners's GILD Position: Q2 2016 in Review

New Amsterdam Partners sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 5,789 shares — an estimated $532K sold.

New Amsterdam Partners first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $7.42M in Q2 2013. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • New Amsterdam Partners reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • New Amsterdam Partners sold 5,789 Gilead Sciences shares in Q2 2016, an estimated $532K.
  • New Amsterdam Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • New Amsterdam Partners's Gilead Sciences position peaked at $7.42M in Q2 2013.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on New Amsterdam Partners's 13F filing for Q2 2016, filed 1 Aug 2016.